Duran et al [25] demonstrated that oncogenic KRAS can activate IKK through the signaling adaptor p62 and other studies have shown that genetic deletion of IKKβ in different cancer models suppresses RAS-induced tumorigenesis [26-28]. Here, IKBKB is linked to cancer.